Celastrol inhibits proliferation and induces chemosensitization through down-regulation of NF-κB and STAT3 regulated gene products in multiple myeloma cells
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Celastrol inhibits proliferation and induces chemosensitization through down-regulation of NF-κB and STAT3 regulated gene products in multiple myeloma cells
Authors
Keywords
-
Journal
BRITISH JOURNAL OF PHARMACOLOGY
Volume 164, Issue 5, Pages 1506-1521
Publisher
Wiley
Online
2011-04-21
DOI
10.1111/j.1476-5381.2011.01449.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Celastrol Attenuates Hypertension-Induced Inflammation and Oxidative Stress in Vascular Smooth Muscle Cells via Induction of Heme Oxygenase-1
- (2010) X. Yu et al. AMERICAN JOURNAL OF HYPERTENSION
- Celastrol: Molecular targets of Thunder God Vine
- (2010) Antero Salminen et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Targeting transcription factor NF-κB to overcome chemoresistance and radioresistance in cancer therapy
- (2010) Feng Li et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Diosgenin, a steroidal saponin, inhibits STAT3 signaling pathway leading to suppression of proliferation and chemosensitization of human hepatocellular carcinoma cells
- (2010) Feng Li et al. CANCER LETTERS
- Molecular targets of celastrol derived from Thunder of God Vine: Potential role in the treatment of inflammatory disorders and cancer
- (2010) Radhamani Kannaiyan et al. CANCER LETTERS
- Targeting apoptosis pathways in cancer by Chinese medicine
- (2010) Min Li-Weber CANCER LETTERS
- Celastrol Suppresses Angiogenesis-Mediated Tumor Growth through Inhibition of AKT/Mammalian Target of Rapamycin Pathway
- (2010) X. Pang et al. CANCER RESEARCH
- Celastrol regulates multiple nuclear transcription factors belonging to HSP90's clients in a dose- and cell type-dependent way
- (2010) Denghai Zhang et al. CELL STRESS & CHAPERONES
- The Current Status and Future of Multiple Myeloma in the Clinic
- (2010) Sundar Jagannath et al. Clinical Lymphoma Myeloma & Leukemia
- Celastrol, a Triterpene, Enhances TRAIL-induced Apoptosis through the Down-regulation of Cell Survival Proteins and Up-regulation of Death Receptors
- (2010) Bokyung Sung et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Celastrol suppresses invasion of colon and pancreatic cancer cells through the downregulation of expression of CXCR4 chemokine receptor
- (2010) Vivek R. Yadav et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Reduction of β-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer's disease
- (2010) Daniel Paris et al. Journal of Neuroinflammation
- NF-κB localization in multiple myeloma plasma cells and mesenchymal cells
- (2010) Concetta Conticello et al. LEUKEMIA RESEARCH
- Dual Inhibition of Akt/Mammalian Target of Rapamycin Pathway byNanoparticle Albumin-Bound–Rapamycin and Perifosine Induces Antitumor Activity in Multiple Myeloma
- (2010) Diana Cirstea et al. MOLECULAR CANCER THERAPEUTICS
- Persistently Activated Stat3 Maintains Constitutive NF-κB Activity in Tumors
- (2009) Heehyoung Lee et al. CANCER CELL
- Celecoxib inhibits MDR1 expression through COX-2-dependent mechanism in human hepatocellular carcinoma (HepG2) cell line
- (2009) Karnati R. Roy et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Synergistic Anti-Cancer Activity by the Combination of TRAIL/APO-2L and Celastrol
- (2009) Hong Zhu et al. CANCER INVESTIGATION
- Celastrol, a novel HSP90 inhibitor, depletes Bcr–Abl and induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation
- (2009) Zhongzheng Lu et al. CANCER LETTERS
- Repression of NHE1 Expression by PPAR Activation Is a Potential New Approach for Specific Inhibition of the Growth of Tumor Cells In vitro and In vivo
- (2009) A. P. Kumar et al. CANCER RESEARCH
- Targeting Inflammatory Pathways for Prevention and Therapy of Cancer: Short-Term Friend, Long-Term Foe
- (2009) B. B. Aggarwal et al. CLINICAL CANCER RESEARCH
- Celastrol Potentiates Radiotherapy by Impairment of DNA Damage Processing in Human Prostate Cancer
- (2009) Yao Dai et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Multiple myeloma
- (2009) Marc S Raab et al. LANCET
- Proteasome inhibitors in the treatment of multiple myeloma
- (2009) J J Shah et al. LEUKEMIA
- Curcumin circumvents chemoresistance in vitro and potentiates the effect of thalidomide and bortezomib against human multiple myeloma in nude mice model
- (2009) B. Sung et al. MOLECULAR CANCER THERAPEUTICS
- Potential pharmacological control of the NF-κB pathway
- (2009) Gautam Sethi et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- SH-5, an AKT inhibitor potentiates apoptosis and inhibits invasion through the suppression of anti-apoptotic, proliferative and metastatic gene products regulated by IκBα kinase activation
- (2008) Gautam Sethi et al. BIOCHEMICAL PHARMACOLOGY
- Multiple myeloma
- (2008) R. A. Kyle et al. BLOOD
- Celastrol inhibits the growth of human glioma xenografts in nude mice through suppressing VEGFR expression
- (2008) Yulun Huang et al. CANCER LETTERS
- Targeting STAT3 in cancer: how successful are we?
- (2008) Peibin Yue et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Antimitotic quinoid triterpenes from Maytenus chuchuhuasca
- (2007) Hiroshi Morita et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now